| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.5 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |